InvestorsHub Logo
Followers 0
Posts 10
Boards Moderated 0
Alias Born 04/02/2013

Re: Everywhereman post# 1888

Wednesday, 04/03/2013 2:03:14 PM

Wednesday, April 03, 2013 2:03:14 PM

Post# of 40502
Excellent, informative post. My comments on Hep C trial were definitely misguided. My point was, INO needed the data to be conclusive to get the ball rolling sort of speak. yes Chrontech owns the Hep C IP, but INO was joint venture thus joint risk.


Again, thanks for the info!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News